Adial Pharmaceuticals Inc (ADIL)

May 03, 2026

EBIT per share of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView

May 03, 2026

Apr 30, 2026

ADIL Stock Price, Quote & Chart | ADIAL PHARMACEUTICALS INC (NASDAQ:ADIL) - ChartMill

Apr 30, 2026

Apr 29, 2026

Adial Pharmaceuticals files patent application for AD04 By Investing.com - Investing.com South Africa

Apr 29, 2026

Apr 29, 2026

Adial Pharmaceuticals files patent application for AD04 - Investing.com

Apr 29, 2026

Apr 29, 2026

Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045 - The Manila Times

Apr 29, 2026

Apr 29, 2026

Adial seeks U.S. patent that could protect its lead alcohol-use drug to 2045 - Stock Titan

Apr 29, 2026

Apr 29, 2026

Adial Pharmaceuticals Files New U.S. Utility Patent Application For AD04 Targeting Alcohol Use Disorder - marketscreener.com

Apr 29, 2026

Apr 28, 2026

Exclusive: Adial Pharmaceuticals clears manufacturing milestone ahead of pivotal study for alcohol use disorder drug - MSN

Apr 28, 2026

Apr 27, 2026

Why did Adial Pharmaceuticals stock plunge over 20% after hours today? - MSN

Apr 27, 2026

Apr 27, 2026

Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight - GlobeNewswire Inc.

Apr 27, 2026

Apr 27, 2026

Adial Pharmaceuticals (ADIL) Submits Application to FDA's National Priority Voucher Program - GuruFocus

Apr 27, 2026

Apr 27, 2026

Adial Pharmaceuticals applies for FDA priority voucher program - Investing.com

Apr 27, 2026

Apr 27, 2026

Adial Pharmaceuticals applies for FDA priority voucher program By Investing.com - Investing.com India

Apr 27, 2026

Apr 27, 2026

Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program - The Manila Times

Apr 27, 2026

Apr 26, 2026

Adial Pharmaceuticals lead drug fits new policy mood as bipartisan bill signals broader lens on alcohol use disorder - MSN

Apr 26, 2026

Apr 25, 2026

Adial Pharmaceuticals (ADIL) price target decreased by 10.26% to 23.80 - MSN

Apr 25, 2026

Apr 23, 2026

EXCLUSIVE: Adial Pharmaceuticals Clears Manufacturing Milestone Ahead Of Pivotal Study For Alcohol Use Disorder Drug - Sahm

Apr 23, 2026

Apr 22, 2026

Adial Pharmaceuticals completes AD04 demonstration batch production By Investing.com - Investing.com Australia

Apr 22, 2026

Apr 22, 2026

ADIL (Adial Pharmaceuticals Inc) reports wider than expected Q4 2025 loss, yet stock notches 2.53 percent gain today.Quick Ratio - UBND thành phố Hải Phòng

Apr 22, 2026

Apr 22, 2026

Adial Pharmaceuticals (ADIL) Advances Production for Phase 3 Cli - GuruFocus

Apr 22, 2026

Apr 22, 2026

Adial Pharmaceuticals completes AD04 demonstration batch production - Investing.com

Apr 22, 2026

Apr 22, 2026

Adial Pharmaceuticals Completes Successful AD04 Demonstration Batch Production - Intellectia AI

Apr 22, 2026

Apr 22, 2026

Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial - The Manila Times

Apr 22, 2026

Apr 22, 2026

EXCLUSIVE: Adial Pharmaceuticals Clears Manufacturing Milestone Ahead Of Pivotal Study For Alcohol Use Di - Benzinga

Apr 22, 2026

Apr 22, 2026

Adial Pharmaceuticals Successfully Completes Manufacturing Of Demonstration Batch Production Enabling Clinical And Registration Production For AD04 Planned Phase 3 Trial - marketscreener.com

Apr 22, 2026

Apr 18, 2026

Adial Pharma (ADIL) Stock: Technical Setup (Flirts with Breakout) 2026-04-18Professional Trade Ideas - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 18, 2026

Apr 12, 2026

Adial Pharmaceuticals regains compliance with Nasdaq stockholders’ equity listing requirement - MSN

Apr 12, 2026

Apr 12, 2026

ADIL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 12, 2026

Apr 10, 2026

Published on: 2026-04-10 14:04:42 - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Adial Pharmaceuticals Files 8-K on Executive Changes and Restricted Stock Award Agreement - Minichart

Apr 10, 2026

Apr 09, 2026

Adial Pharmaceuticals Implements New Executive Equity Compensation Plan - TipRanks

Apr 09, 2026

Apr 09, 2026

Adial Pharmaceuticals grants restricted stock awards to Cary Claiborne, Vinay Shah and Tony Goodman - TradingView

Apr 09, 2026

Apr 09, 2026

[Form 4] ADIAL PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan

Apr 09, 2026

Apr 09, 2026

Adial Pharmaceuticals (ADIL) director receives 9,185 stock options at $1.64 strike - Stock Titan

Apr 09, 2026

Apr 09, 2026

Adial (NASDAQ: ADIL) awards RSAs and stock options to board members - Stock Titan

Apr 09, 2026

Apr 09, 2026

Director at Adial (NASDAQ: ADIL) receives 9,185 restricted shares - Stock Titan

Apr 09, 2026

Apr 09, 2026

Adial Pharmaceuticals (ADIL) CFO receives 17,325-share restricted stock grant - Stock Titan

Apr 09, 2026

Apr 09, 2026

ADIAL (ADIL) director awarded 9,185 restricted shares in equity grant - Stock Titan

Apr 09, 2026

Apr 09, 2026

Adial Pharmaceuticals (NASDAQ: ADIL) CEO granted 37,985 shares - Stock Titan

Apr 09, 2026

Apr 06, 2026

Is Adial Pharma (ADIL) Stock Trending Down | Price at $1.79, Up 5.92%Community Volume Signals - Cổng thông tin điện tử tỉnh Lào Cai

Apr 06, 2026

Apr 02, 2026

Investor Mood: Will Adial Pharmaceuticals Inc benefit from government policy2026 Selloffs & AI Enhanced Trading Signals - baoquankhu1.vn

Apr 02, 2026

Apr 02, 2026

Is Adial Pharma (ADIL) Stock Overpriced Now | Price at $1.69, Down 2.31%Cycle Analysis - Cổng thông tin điện tử tỉnh Lào Cai

Apr 02, 2026

Mar 31, 2026

Hedge Fund Bets: Whats the MACD signal for Adial Pharmaceuticals Inc2026 Dividend Review & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Mar 31, 2026